Invention Grant
- Patent Title: Vitamins and alpha keto acid compositions for use in a treatment program for chronic kidney disease patients
-
Application No.: US17945043Application Date: 2022-09-14
-
Publication No.: US12109254B2Publication Date: 2024-10-08
- Inventor: Edgar Lee Hull, Jr. , Narashima Murthy , Sridhara Am
- Applicant: Edgar Lee Hull, Jr.
- Applicant Address: US WI Middletown
- Assignee: Edgar Hull
- Current Assignee: Edgar Hull
- Current Assignee Address: US WI Verona
- The original application number of the division: US17061952 2020.10.02
- Main IPC: A61K38/44
- IPC: A61K38/44 ; A61K31/122 ; A61K31/197 ; A61K31/198 ; A61K31/355 ; A61K31/405 ; A61K31/4172 ; A61K31/4415 ; A61K31/455 ; A61K31/51 ; A61K31/519 ; A61K31/525 ; A61K31/714 ; A61K33/00 ; A61K33/04 ; A61K33/30

Abstract:
A low nitrogen protein food composition Albutrix™ for use by kidney patients in Stages 3, 4, 4a, 4b, and 5, who are not on dialysis, in a treatment program comprising administering daily a: low nitrogen diet; low nitrogen protein food comprising magnesium and/or calcium salts of alpha keto acids; and time released vitamin. The vitamin comprises the active ingredients of: Zinc; Selenium; Vitamins B1, B2, B6, B12, B5, E, and K2; Niacin; superoxide dismutase; catalase; glutathione and Folate; and excludes calcium, magnesium, phosphorus, sodium, manganese, fluoride, Vitamin D and K1. The low nitrogen food contains daily up to 300 mg of nitrogen; and at least five alpha keto analogues of magnesium and/or calcium salts of: leucine, isoleucine, methionine (MEMS-II), phenylalanine (PAMS-I), and valine. The treatment results in an increase of Glomerular Filtration Rate (GFR), a decrease in blood urea levels, and a decrease in creatinine levels.
Public/Granted literature
Information query
IPC分类: